Business Context and Reporting Period
This Form 8-K is filed by Anthem, Inc. (now Elevance Health, Inc.) on April 9, 2002. The report serves as a Regulation FD disclosure regarding upcoming meetings between company officers and securities analysts/investors scheduled for the week ended April 12, 2002.
Key Financial Metrics
The filing text does not provide specific financial values for revenue, profit, cash flow, margins, debt, or liquidity. The document references a press release from February 6, 2002, which contained earnings expectations, but does not restate those figures within this report.
Material Changes
No material financial changes or operational updates are detailed in this specific filing. The primary purpose is to announce the confirmation of previously issued earnings expectations during upcoming investor meetings.
Guidance, Outlook, and Risks
Outlook: Management expects to confirm the Company's ability to meet the earnings expectations provided in the February 6, 2002 press release.
Risks and Uncertainties: The filing includes a standard caution regarding forward-looking statements, listing the following risks that could cause actual results to differ materially from projections:
- Trends in health care costs and utilization rates.
- Ability to secure sufficient premium rate increases.
- Competitor pricing below market trends of increasing costs.
- Increased government regulation of health benefits and managed care.
- Significant acquisitions or divestitures by major competitors.
- Introduction and utilization of new prescription drugs and technology.
- A downgrade in financial strength ratings.
- Litigation targeted at health benefits companies.
- Ability to contract with providers consistent with past practice.
- General economic downturns.
Investor Verification Checklist
- Verify the specific earnings expectations detailed in the February 6, 2002 press release (filed as Exhibit 99 to the prior Form 8-K).
- Review the Company's final Prospectus dated October 29, 2001, for the initial public offering.
- Examine periodic reports (Form 10-K, 10-Q, and 8-K) for detailed financial data and risk factors.
- Monitor upcoming analyst meetings for any updates to the February 2002 guidance.